Traditional and Alternative Medicine Act

Also known as: TAMA — the standard abbreviation in Philippine health policy usage · TAMA of 1997 — the statutory short title's dating · Republic Act No. 8423 — the citation form · Traditional and Alternative Medicine Act of 1997 — the full statutory short title

Medicine

Definition

The Traditional and Alternative Medicine Act (TAMA), formally Republic Act No. 8423, the Traditional and Alternative Medicine Act of 1997, is the Philippine law approved on December 9, 1997 — “An Act creating the Philippine Institute of Traditional and Alternative Health Care (PITAHC), providing a development fund, and for other purposes” — which established the country’s national program to research, validate, and integrate traditional and alternative medicine into the national health care system. (LawPhil — RA No. 8423) The Act’s declaration of policy commits the state to improving the quality of health care through the integration of proven traditional and alternative modalities, and — notably for its time — provides that indigenous cultural societies and communities may own their traditional knowledge, require acknowledgment of its source, and demand a share of the returns from its commercial exploitation. (LawPhil — RA No. 8423) The Philippine Institute of Traditional and Alternative Health Care, the agency the law created — described on its own site as a government-owned and controlled corporation attached to the Department of Health — promotes and integrates traditional, complementary, and alternative medicine in the national health care system; PITAHC dates its establishment to December 1997 and credits the law to Senator Juan M. Flavier, the former health secretary. (PITAHC — official site, LawPhil — RA No. 8423)

The law defines its field in Section 4 — traditional medicine, biomedicine (or allopathy), alternative health care modalities (illustrated in the statute by reflexology, acupressure, and chiropractics), herbal medicines, natural products, and traditional healers — while the institute it created has since organized its work around an expanded roster of modalities it recognizes and appraises: acupuncture, chiropractic, hilot, homeopathy, naturopathy, osteopathy, traditional Chinese medicine, tuina massage, anthroposophic medicine, and ayurveda, alongside its advocacy of the ten DOH-identified, scientifically validated medicinal plants. (LawPhil — RA No. 8423, PITAHC — official site)

Identities

Source Type	Identity
Wikipedia	N/A (no standalone article for the act or for PITAHC as of this entry’s verification)
Wikidata	N/A (no matching entity in Wikidata as of this entry’s verification)
DBpedia	N/A
ProductOntology	N/A
Wiktionary	traditional medicine (English noun — a system of medicine developed before the era of modern medicine, especially one associated with a single culture; the phrase, not the statute)
Library of Congress Subject Headings (LCSH)	Medicine, Traditional — Law and legislation — Philippines (the act is cataloged in the subdivided subject pattern built on the established heading Medicine, Traditional)
MeSH	Medicine, Traditional (MeSH D008519)
NCBI Taxonomy	N/A
AGROVOC	N/A
Google Scholar	Traditional and Alternative Medicine Act TAMA Republic Act 8423 1997 PITAHC Philippine Institute of Traditional and Alternative Health Care traditional medicine integration DOH herbal medicine hilot indigenous knowledge
ConceptNet	N/A
OpenCyc	N/A

Also Known As

TAMA — the standard abbreviation in Philippine health policy usage
TAMA of 1997 — the statutory short title’s dating
Republic Act No. 8423 — the citation form
Traditional and Alternative Medicine Act of 1997 — the full statutory short title

Examples and Analogies

A bridge law between two medical worlds: TAMA works like a treaty between an established state and a neighboring society already inside the borders — rather than licensing folk practice piecemeal or ignoring it, the statute created a standing institute to negotiate the terms: research, validation, standards, and staged integration into the national system. (LawPhil — RA No. 8423)
The promotion-regulation pairing: the law placed the advocacy of traditional medicine in one attached agency while leaving product policing with the food-and-drug regulator — Section 13 requires PITAHC to formulate standards of manufacture, marketing, and quality control with the Bureau of Food and Drugs — so the same herbal preparation can be promoted by PITAHC and registered, labeled, and policed by the regulator that became today’s FDA under the Food and Drug Administration Act of 2009. (LawPhil — RA No. 8423, LawPhil — RA No. 9711)
A funded start-up inside DOH: the Act seeded the institute with a development fund of ₱50 million in its first year, ₱75 million in the second, and ₱100 million in the third, drawn from Duty Free Philippines earnings, with administrative costs capped at 15 percent — venture capital terms for a public health agency. (LawPhil — RA No. 8423)
Verified statutory and agency data:
Approval: December 9, 1997, Tenth Congress, Third Regular Session (LawPhil text); PITAHC’s own institutional account dates its establishment to December 7, 1997 — a variance between the statutory text and the agency record (LawPhil — RA No. 8423, PITAHC — official site)
Authorship: credited by PITAHC to Senator Juan M. Flavier (PITAHC — official site)
Policy: Sec. 2 — integration of proven modalities; indigenous societies’ ownership of traditional knowledge, acknowledgment, and a share of commercial returns (LawPhil — RA No. 8423)
Objectives: Sec. 3 — research and development, promotion of proven modalities, training, codes of ethics and standards, protection of indigenous resources, delivery systems, and promotion at conventions and tourism venues (LawPhil — RA No. 8423)
Definitions: Sec. 4 — traditional medicine, biomedicine/allopathy, alternative modalities (e.g., reflexology, acupressure, chiropractics), herbal medicines, natural products, manufacture, traditional healers, intellectual property rights (LawPhil — RA No. 8423)
Institute: Sec. 5 — PITAHC created as a corporation attached to the DOH, headquarters in Metro Manila, authority to open regional offices; headed by a Director General with a six-year term; Board of Trustees chaired ex officio by the Secretary of Health, with representatives of DOST, DENR, DA, DECS, and CHED and six presidential appointees from practitioner, academic, natural-food-industry, and environmental sectors (LawPhil — RA No. 8423, PITAHC — official site)
Fund: Sec. 15 — ₱50M/₱75M/₱100M from Duty Free Philippines earnings, 15 percent administrative cap (LawPhil — RA No. 8423)
Transitions: Sec. 17 — the DOH Traditional Medicine Unit’s functions, personnel, and assets transferred to the institute; Sec. 19 — implementing rules within 180 days of the Board’s first meeting; effectivity 15 days after publication (LawPhil — RA No. 8423)
Agency practice: PITAHC’s recognized modalities (acupuncture, chiropractic, hilot, homeopathy, naturopathy, osteopathy, traditional Chinese medicine, tuina massage, anthroposophic medicine, ayurveda); ten DOH-identified validated medicinal plants, four of them listed on its site — ampalaya (diabetes mellitus), lagundi (cough and asthma), sambong (kidney stones), tsaang gubat (stomach aches); 683 registered practitioners and 54 accredited centers as posted (PITAHC — official site)

Usage Scenarios

1. Citing the Legal Basis of Traditional Medicine Policy

TAMA is the primary statute for any question of traditional-medicine policy in the Philippines — the mandate, definitions, and institutional design that later administrative practice, including PITAHC’s certification and accreditation registries, all trace to Sections 2 through 13 of the Act. (LawPhil — RA No. 8423, PITAHC — official site)

2. Accrediting Hilot and Traditional Practice

The framework this wiki’s Hilot massage entry describes — PITAHC setting competency standards and accrediting hilot practitioners, training centers, and clinics under TAMA — is the Act’s most visible daily application: the law converted an unregulated healing tradition into a certified occupation, listed among the institute’s recognized modalities. (PITAHC — official site, LawPhil — RA No. 8423)

3. Regulating Herbal and Natural Products

For products rather than practices, TAMA’s Section 13 route applies: standards of manufacture, marketing, and quality control are formulated with the food-and-drug regulator — the bureau created by the Food, Drug, and Cosmetic Act of 1963 and strengthened and renamed the Food and Drug Administration by RA 9711 (2009) — so a herbal medicine is promoted under TAMA but registered and labeled under the regulatory statutes this wiki’s entries on drug administration and dietary-supplement regulation document, including the food-supplement regime’s “No Approved Therapeutic Claims” discipline. (LawPhil — RA No. 8423, LawPhil — RA No. 3720, LawPhil — RA No. 9711)

4. Protecting Indigenous Medical Knowledge

The Act’s Section 2 provisions — indigenous ownership of traditional knowledge, acknowledgment of source, and a share of commercial returns — are cited as an early statutory precursor of Philippine access-and-benefit-sharing policy, applied whenever a validated plant remedy or healing practice moves from community use to commercial product. (LawPhil — RA No. 8423)

5. Researching Integration Into the National Health System

Scholars of health-system integration use PITAHC’s research program — its four priority clusters covering documentation of traditional knowledge, safety and quality of natural products, clinical research on modalities, and policy and standards research — as the operational record of the Act’s Section 3 objectives. (PITAHC — official site)

Strategies

Attach, don’t absorb: creating PITAHC as a corporation attached to the DOH — rather than a bureau inside it — gave the program a dedicated board, fund, and directorate while keeping policy direction with the health department, the attached-agency model this wiki’s Department of Health entry documents. (LawPhil — RA No. 8423, PITAHC — official site)
Validate before integrating: the statute’s repeated qualifiers — “proven” modalities, “scientifically” validated plants — made evidence the condition of integration, protecting the program from wholesale adoption of untested practice. (LawPhil — RA No. 8423, PITAHC — official site)
Split promotion from policing: pairing PITAHC’s advocacy with the food-and-drug regulator’s product control (Sec. 13) avoided making one agency both cheerleader and enforcer — the separation that later food-supplement and drug regulation built on. (LawPhil — RA No. 8423)
Fund the start, then appropriate: seeding the institute from Duty Free Philippines earnings before shifting to annual appropriations gave the new agency guaranteed early capital independent of the budget cycle. (LawPhil — RA No. 8423)
Carry over the predecessor: Section 17’s transfer of the DOH Traditional Medicine Unit’s functions, personnel, and assets made the institute the continuation of an existing program, not a start from zero. (LawPhil — RA No. 8423)

Security and Safety Measures

Standards as consumer protection: Section 13’s manufacture, marketing, and quality-control standards — formulated with the food-and-drug regulator — are the Act’s core safety instrument against adulterated or mislabeled traditional products. (LawPhil — RA No. 8423)
Certification of practitioners: PITAHC’s registry of certified practitioners and accredited facilities — 683 and 54 respectively as posted on its site — operationalizes the competency standards that keep manual therapies like hilot within safe practice bounds. (PITAHC — official site)
Codes of ethics and practice: Section 3 and Section 6 direct the institute to formulate codes of ethics and standards of practice for traditional and alternative health care, the professional discipline layer the statute builds into the field. (LawPhil — RA No. 8423)
Indigenous-resource protection as safeguard: Section 2’s knowledge-ownership and benefit-sharing provisions protect communities from uncompensated extraction of their medical heritage — a safety measure for knowledge holders, not only consumers. (LawPhil — RA No. 8423)
For researchers: note the date variance — the LawPhil statutory text records approval on December 9, 1997, while PITAHC’s own site says the institute was established December 7, 1997; cite the statutory text for the act’s approval and the agency account for the agency’s founding narrative. (LawPhil — RA No. 8423, PITAHC — official site)

Historical Context

Before the Act, traditional medicine in the Philippines lived in a paradox the law’s framers named: practices used by much of the population — herbal remedies, hilot, the ministrations of traditional healers — stood outside the formal system that regulated biomedicine, the domain defined in the statute as “allopathy.” The DOH had assembled a Traditional Medicine Unit and a program of scientifically validated medicinal plants, and Senator Juan M. Flavier — health secretary before entering the Senate — carried the program into legislation: RA 8423, approved December 9, 1997, created PITAHC as an attached corporation, transferred the unit’s functions to it, funded it with a three-year escalating appropriation from Duty Free Philippines earnings, and ordered implementing rules within 180 days of the board’s first meeting. (LawPhil — RA No. 8423, PITAHC — official site)

The institute built the apparatus the Act prescribed — research clusters, practitioner certification, facility accreditation, advocacy of the validated plants and of modalities from acupuncture to hilot — while the regulatory half of the statute matured alongside it: the Bureau of Food and Drugs that Section 13 named as PITAHC’s standards partner was the agency created by the Food, Drug, and Cosmetic Act of 1963 and was strengthened and renamed the Food and Drug Administration by RA 9711 in 2009, the lineage this wiki’s entries on drug administration and dietary-supplement regulation carry. PITAHC describes itself today as more than twenty-eight years into the mandate — the working proof of the Act’s premise that traditional and alternative medicine could be researched, standardized, and brought inside the national health system rather than left outside it. (PITAHC — official site, LawPhil — RA No. 3720, LawPhil — RA No. 9711)

Challenges and Controversies

The Date Variance in the Record

The statute’s own text, as archived by the LawPhil Project, records approval on December 9, 1997; PITAHC’s institutional pages date the institute’s establishment to December 7, 1997. The two days’ difference persists across the literature — this entry reports both and treats the statutory text as controlling for the act’s approval — a routine but real discrepancy for researchers to handle. (LawPhil — RA No. 8423, PITAHC — official site)

Integration Versus Evidence

The Act’s core tension is how much validation integration requires: the statute says “proven” and “scientifically validated,” yet the modalities PITAHC lists — from acupuncture and hilot to homeopathy and anthroposophic medicine — carry unequal evidence bases, and critics of integrative medicine policy argue that state promotion lends unearned credibility to practices whose efficacy is contested; defenders answer that documentation, standards, and research — the institute’s mandate — are precisely how a health system brings folk practice to the test. (PITAHC — official site, LawPhil — RA No. 8423)

The Boundary With Product Regulation

TAMA’s division of labor — PITAHC promotes, the food-and-drug regulator polices — leaves a contested borderland: herbal preparations may be marketed as food supplements with “No Approved Therapeutic Claims” while being simultaneously advocated as traditional medicines, the ambiguity this wiki’s entry on dietary-supplement regulation documents and the advertising and direct-selling channels routinely exploit. (LawPhil — RA No. 8423, LawPhil — RA No. 9711)

Indigenous Knowledge and Benefit-Sharing

Section 2’s recognition of indigenous ownership of traditional knowledge was ahead of its time, but its enforcement — acknowledgment of source, a share of commercial returns — depends on implementing practice that communities have often found slow; the gap between the statute’s promise and realized benefit remains the standing critique of Philippine bioprospecting and traditional-knowledge policy. (LawPhil — RA No. 8423)